Doris Damian

1.4k total citations
38 papers, 959 citations indexed

About

Doris Damian is a scholar working on Pathology and Forensic Medicine, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Doris Damian has authored 38 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 11 papers in Genetics and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Doris Damian's work include Chronic Lymphocytic Leukemia Research (11 papers), Multiple Sclerosis Research Studies (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). Doris Damian is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Multiple Sclerosis Research Studies (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). Doris Damian collaborates with scholars based in United States, Germany and United Kingdom. Doris Damian's co-authors include Daniel L. Hartl, Matthew Hegreness, Roy Kishony, Noam Shoresh, Ophir Handzel, Donald K. Eddington, Aayesha M. Khan, Paul D. Sampson, Joseph B. Nadol and Peter Guttorp and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Geophysical Research Atmospheres and Neurology.

In The Last Decade

Doris Damian

38 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris Damian United States 16 228 209 198 170 128 38 959
Xiaoli Zhong China 19 54 0.2× 531 2.5× 161 0.8× 32 0.2× 127 1.0× 97 1.2k
Qiang Hao China 22 65 0.3× 253 1.2× 58 0.3× 40 0.2× 188 1.5× 72 1.2k
Lai China 17 32 0.1× 265 1.3× 61 0.3× 8 0.0× 91 0.7× 119 1.0k
Mark J. Hoenerhoff United States 23 113 0.5× 668 3.2× 14 0.1× 24 0.1× 338 2.6× 102 1.8k
Chanin Limwongse Thailand 20 98 0.4× 511 2.4× 22 0.1× 67 0.4× 79 0.6× 94 1.2k
Francine Baumann France 19 46 0.2× 430 2.1× 34 0.2× 9 0.1× 181 1.4× 52 1.8k
Sarah Sheikh United States 18 1.3k 5.8× 479 2.3× 47 0.2× 15 0.1× 452 3.5× 48 2.2k
Francesca Rosini Italy 18 94 0.4× 435 2.1× 74 0.4× 9 0.1× 134 1.0× 55 1.3k
Fei Xu China 21 32 0.1× 696 3.3× 41 0.2× 6 0.0× 93 0.7× 79 1.2k

Countries citing papers authored by Doris Damian

Since Specialization
Citations

This map shows the geographic impact of Doris Damian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Damian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Damian more than expected).

Fields of papers citing papers by Doris Damian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Damian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Damian. The network helps show where Doris Damian may publish in the future.

Co-authorship network of co-authors of Doris Damian

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Damian. A scholar is included among the top collaborators of Doris Damian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Damian. Doris Damian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jack, Dominic, Doris Damian, Axel Nolting, & Andrew Galazka. (2021). COVID-19 in patients with multiple sclerosis treated with cladribine tablets: An update. Multiple Sclerosis and Related Disorders. 51. 102929–102929. 19 indexed citations
2.
Cree, Bruce, James D. Bowen, Hans‐Peter Hartung, et al.. (2020). Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study. Multiple Sclerosis and Related Disorders. 49. 102695–102695. 8 indexed citations
3.
Leist, Thomas, S. D. Cook, Gıancarlo Comı, et al.. (2020). Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis. Multiple Sclerosis and Related Disorders. 46. 102572–102572. 43 indexed citations
4.
Khanna, Dinesh, Donald P. Tashkin, Athol U. Wells, et al.. (2020). STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis–associated Interstitial Lung Disease. The Journal of Rheumatology. 48(8). 1295–1298. 21 indexed citations
5.
Giovannoni, Gavin, Andrew Galazka, Thomas Leist, et al.. (2020). Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety. Drug Safety. 43(7). 635–643. 27 indexed citations
6.
Cook, Stuart D., Gavin Giovannoni, Thomas Leist, et al.. (2020). Updated safety of cladribine tablets in the treatment of patients with multiple sclerosis: Integrated safety analysis and post-approval data (1656). Neurology. 94(15_supplement). 2 indexed citations
7.
Cook, Stuart D., Gavin Giovannoni, Thomas Leist, et al.. (2020). Updated Safety of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis: Integrated Safety Analysis and Post-Approval Data. Multiple Sclerosis and Related Disorders. 37. 101599–101599. 4 indexed citations
8.
9.
10.
11.
Freedman, Mark S., Thomas Leist, Gıancarlo Comı, et al.. (2016). Efficacy of Cladribine Tablets in ORACLE Study Patients Who Retrospectively Met 2010 McDonald Multiple Sclerosis (MS) Criteria at Baseline (P3.035). Neurology. 86(16_supplement). 2 indexed citations
12.
Handzel, Ophir, et al.. (2013). Smartphone-Based Hearing Test as an Aid in the Initial Evaluation of Unilateral Sudden Sensorineural Hearing Loss. Audiology and Neurotology. 18(4). 201–207. 69 indexed citations
13.
Damian, Doris, et al.. (2009). C125 A critical analysis of perioperative mortality and morbidity from radical cystectomy. European Urology Supplements. 8(8). 699–699. 1 indexed citations
14.
Adourian, Aram, Ezra G. Jennings, Raji Balasubramanian, et al.. (2008). Correlation network analysis for data integration and biomarker selection. Molecular BioSystems. 4(3). 249–259. 41 indexed citations
15.
Khan, Aayesha M., Ophir Handzel, Barbara J. Burgess, et al.. (2005). Is Word Recognition Correlated With the Number of Surviving Spiral Ganglion Cells and Electrode Insertion Depth in Human Subjects With Cochlear Implants?. The Laryngoscope. 115(4). 672–677. 126 indexed citations
16.
Khan, Aayesha M., Ophir Handzel, Donald K. Eddington, Doris Damian, & Joseph B. Nadol. (2005). Effect of Cochlear Implantation on Residual Spiral Ganglion Cell Count as Determined by Comparison with the Contralateral Nonimplanted Inner Ear in Humans. Annals of Otology Rhinology & Laryngology. 114(5). 381–385. 39 indexed citations
17.
Burbacher, Thomas M., Danny D. Shen, Bojan Lalovic, et al.. (2004). Chronic maternal methanol inhalation in nonhuman primates (Macaca fascicularis): Exposure and toxicokinetics prior to and during pregnancy. Neurotoxicology and Teratology. 26(2). 201–221. 4 indexed citations
18.
Damian, Doris, Paul D. Sampson, & Peter Guttorp. (2001). Bayesian estimation of semi-parametric non-stationary spatial covariance structures. Environmetrics. 12(2). 161–178. 70 indexed citations
19.
Sheppard, Lianne & Doris Damian. (2000). Estimating short-term PM effects accounting for surrogate exposure measurements from ambient monitors. Environmetrics. 11(6). 675–687. 8 indexed citations
20.
Burbacher, Thomas M., et al.. (1999). Reproductive and offspring developmental effects following maternal inhalation exposure to methanol in nonhuman primates.. PubMed. i–ii, 1. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoli Zhong Breakdown of academic impact, for papers by Qiang Hao Breakdown of academic impact, for papers by Lai Breakdown of academic impact, for papers by Mark J. Hoenerhoff Breakdown of academic impact, for papers by Chanin Limwongse Breakdown of academic impact, for papers by Francine Baumann Breakdown of academic impact, for papers by Sarah Sheikh Breakdown of academic impact, for papers by Francesca Rosini Breakdown of academic impact, for papers by Fei Xu
Rankless by CCL
2026